A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin

Cancer Research

Volumn 61, Issue 17, 2001, Pages 6428-6436

  Li, Yuanhao ^a   Yu, De Chao ^a   Chen, Yu ^a   Amin, Pinky ^a   Zhang, Hong ^a   Nguyen, Natalie ^a   Henderson, Daniel R ^a  

^a Calydon Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; DOXORUBICIN; E1A PROTEIN; E1B PROTEIN; GENE PRODUCT; ONCOFETAL ANTIGEN; UNCLASSIFIED DRUG;

ADENOVIRUS; ADENOVIRUS CV890; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; GENE CONTROL; GENE EXPRESSION; GENOME; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; TUMOR VOLUME; VIRUS REPLICATION; WESTERN BLOTTING;

ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; ADENOVIRUS E1B PROTEINS; ADENOVIRUS E3 PROTEINS; ALPHA-FETOPROTEINS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; CYTOPATHOGENIC EFFECT, VIRAL; DOXORUBICIN; GENETIC VECTORS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PROSTATIC NEOPLASMS; RESPONSE ELEMENTS; RIBOSOMES; RNA, MESSENGER; TUMOR CELLS, CULTURED; VIRUS REPLICATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035417931     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Cancer incidence in five continents. Comparability and quality of data
2. Treatment of hepatocellular carcinoma: Too many options?
3. Therapy of unresectable hepatocellular carcinoma
4. Radical resection combined with liver transplantation for foregut tumors
5. Primary treatment of hepatocellular carcinoma by arterial chemoembolization
6. Overexpression of the MDRI gene and P-glycoprotein in human hepatocellular carcinoma
7. Prostate attenuated replication competent adenovirus (ARCA) CN706: A selective cytotoxic for prostate-specific antigen-positive prostate cancer cells
8. The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts
9. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy
10. Expression and hypomethylation of α-fetoprotein gene in unicentric and multicentric human hepatocellular carcinomas
11. Regulation and activities of α-fetoprotein
12. A position-dependent silencer plays a major role in repressing α-fetoprotein expression in human hepatoma
13. Cell-specific enhancer activity in a far upstream region of the human α-fetoprotein gene
14. A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma
15. Adenovirus promoters and EIA transactivation
16. Adenovirus type 5 early region 1b gene product is required for efficient shutoff of host protein synthesis
17. Adenovirus EIA under the control of heterologous promoters: Wide variation in EIA expression levels has little effect on virus replication
18. Replicative adenoviruses for cancer therapy
19. Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel
20. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability
21. Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity
22. Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines
23. Internal initiation of translation in eukaryotes: The picornavirus paradigm and beyond
24. Viral transactivating proteins
25. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector
26. Characterization of cell lines established from human hepatocellular carcinoma
27. Gene therapy for cancer
28. Evaluation of the genotoxicity of 4-diethyl-amino-4′-nitroazobenzene and seven analogues
29. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration
30. Efficiency of adenovirus-mediated gene transfer into hepatocytes by liver asanguineous perfusion method
31. Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: Implications and proposals for human therapy